Emara团队于2014年在《Therapeutic Advances in Gastroenterology》上发表了一项将罗伊氏乳杆菌DSM 17938和罗伊氏乳杆菌ATCC PTA 6475联合菌株作为标准三联疗法的辅助疗法用于幽门螺杆菌感染患者治疗的临床研究,主要目的是测试在标准三联疗法中加入罗伊氏乳杆菌是否能提高幽门螺杆菌感染的根除率、改善临床症状以及病理指标。 重...
每天补充两片含罗伊氏乳杆菌DSM 17938和罗伊氏乳杆菌ATCC PTA 6475的益生菌咀嚼片对治疗肠易激综合征是安全有效的,可减少18-65岁成人的IBS相关症状,改善粪便一致性,并减少与焦虑相关的症状,提高患者生活质量。 文献来源 Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to...
ATCC PTA 6475 (LR) is a well-known probiotic that has been shown to be beneficial to the gastrointestinal (GI) system. In addition, LR has been shown to secrete beneficial immunomodulatory factors. In previous studies, we demonstrated that LR can modulate inflammatory genes in the GI tract ...
英文名称:Lactobacillus reuteri 尺寸:冻干粉 特性:0代母种 灭菌情况:灭菌,单一菌种 储存条件:4-10℃ 大包装询价 产品介绍相关文档质检证书(COA)相关文献订购须知 菌种名:罗伊氏乳杆菌 拉丁名:Lactobacillus reuteri 菌种编号:SHMCC(SHBCC) D24591 其他编号:DSM26866 ...
reuteri (ATCC PTA 6475) and its heat-killed (postbiotic) form on Ovx-induced bone loss. Adult female mice (BALB/c) were randomly divided into four groups: group C-control (sham); group OVX-C-Ovx; group OVX-POS-Ovx + heat-killed probiotic; group OVX-PRO-Ovx + probiotic. L. reuteri...
LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALSThe method of the present invention includes the lactic bacteria strain selected, effectively prevent in bone loss people and bacterial strain having a selection according to the method presented. Selection ...
LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALSThe present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The ...
LACTOBACILLUS REUTERI ATCC PTA 6475 FOR USE IN PREVENTION OR TREATMENT OF BONE LOSS IN MAMMALSThe present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The ...
The treatment of Bacillus acidi lactici REUTERI ATCC PTA 6475 or osteoporosis IN mammals for using IN to preventThe method of the present invention includes the lactic bacteria strain selected, effectively prevent in bone loss people and bacterial strain having a selection according to the method ...
The folylpolyglutamate synthase gene in probiotic Lactobacillus reuteri ATCC PTA 6475 contributes to its anti‐inflammatory activity.: P‐026.F ZhangD SaulnierC ThomasJ SpinlerP HemarajataA GrimmT HongM KalkumJ VersalovicInflammatory Bowel Diseases...